Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Safe, broad-spectrum quinolones from Wakunaga

Sep. 20, 1996

Antibacterial compositions for MRSA

Sep. 20, 1996

New quinolone from Bayer undergoing extensive evaluation

Sep. 20, 1996

Antiinfective drugs in development at Daiichi

Sep. 13, 1996

Antiinfective R&D at Toyama

Sep. 13, 1996

Antirhinovirus compounds from Lilly

Sep. 13, 1996

Antibacterial 2-pyridones, a novel class of DNA gyrase inhibitors

Sep. 13, 1996

Merck & Co. discloses novel antifungal agent

Sep. 13, 1996

Natural antibacterial agent reported by Korean researchers

Sep. 13, 1996

Antibacterial agents disclosed by Hokuriku

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...